Baker Bros. Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $605M | Buy |
|
|||||
|
2022
Q3 | $501M | Hold |
|
|||||
|
2022
Q2 | $451M | Buy |
|
|||||
|
2022
Q1 | $533M | Hold |
|
|||||
|
2021
Q4 | $611M | Hold |
|
|||||
|
2021
Q3 | $724M | Buy |
|
|||||
|
2021
Q2 | $466M | Hold |
|
|||||
|
2021
Q1 | $456M | Hold |
|
|||||
|
2020
Q4 | $590M | Hold |
|
|||||
|
2020
Q3 | $546M | Buy |
|
|||||
|
2020
Q2 | $501M | Hold |
|
|||||
|
2020
Q1 | $382M | Hold |
|
|||||
|
2019
Q4 | $472M | Hold |
|
|||||
|
2019
Q3 | $327M | Hold |
|
|||||
|
2019
Q2 | $390M | Hold |
|
|||||
|
2019
Q1 | $399M | Buy |
|
|||||
|
2018
Q4 | $178M | Hold |
|
|||||
|
2018
Q3 | $201M | Hold |
|
|||||
|
2018
Q2 | $189M | Hold |
|
|||||
|
2018
Q1 | $186M | Buy |
|
|||||
|
2017
Q4 | $105M | Buy |
|
|||||
|
2017
Q3 | $85.1M | Buy |
|
|||||
|
2017
Q2 | $48.6M | Buy |
|
|||||
|
2017
Q1 | $37.8M | Buy |
|
|||||
|
2016
Q4 | $20.7M | Buy |
|
|||||
|
2016
Q3 | $15M | Hold |
|
|||||
|
2016
Q2 | $9.89M | Buy |
|
|||||
|
2016
Q1 | $9.38M | Hold |
|
|||||
|
2015
Q4 | $9.26M | Buy |
|
|||||
|
2015
Q3 | $7.71M | Buy |
|
|||||
|
2015
Q2 | $1.77M | Hold |
|
|||||
|
2015
Q1 | $1.74M | Buy |
|